Pharmafile Logo
Pharmafocus logo
Advanced Search
nhssss

NHS sets out plans to deal with the second phase of the pandemic

May 1, 2020
Medical Communications COVID-19, coronavirus

The NHS has set out plans to step up its non-COVID-19 services over the next six weeks. A letter from …

News
800px-european_commission_flags

Positive CHMP opinion for BMS and Acceleron’s Reblozyl in transfusion-dependent anaemia sub-populations

May 1, 2020
Medical Communications, Sales and Marketing Acceleron, Bristol-Myers Squibb, EU, Reblozyl

Bristol Myers Squibb and Acceleron Pharma’s Reblozyl (luspatercept) has secured a positivr opinion from the European Medicines Agency’s Committee for Medicinal …

News
facemask

COVID-19 pandemic likely to last two years, study says

May 1, 2020
Medical Communications COVID-19, coronavirus, pandemic

The coronavirus pandemic is likely to last as long as two years and will not be properly controlled until two-thirds …

News

Vertex’s Kalydeco seizes EU CHMP recommendation for Kalydeco in R117H+ cystic fibrosis

May 1, 2020
Medical Communications, Sales and Marketing Europe, Kalydeco, Vertex, cystic fibrosis

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given its recommendation for the approval …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

May 1, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Gilead, UK, coronaviurs

The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …

News
judge-gavel-1461966002dbr

Teva’s cancer drug Bendeka protected from generics until 2031, judge rules

April 30, 2020
Business Services Bendeka, Teva, Teva and Eagle

A US federal judge has ruled that generic versions of the cancer treatment Bendeka infringe on four separate patents, and …

News
512px-oxford_university_colleges-all_souls1

AstraZeneca joins forces with University of Oxford to develop and manufacture potential coronavirus vaccine

April 30, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, University of Oxford, coronavirus, pharma

A “landmark” partnership has been struck between AstraZeneca and the University of Oxford in the ongoing battle against COVID-19, with …

News
desantis

More than half of US states will relax lockdowns by the end of the week

April 30, 2020
Business Services COVID-19, Lockdown, coronavirus, quaratine

Nearly half of US states will have their ‘stay-at-home’ orders expire this week, paving the way for much of the …

News
gilead-speeds-manufacture-of-experimental-covid-19-drug-biospace-4-5-20-495x350

Two studies reveal “positive” data for Gilead’s remdesivir in hospitalised COVID-19 patients

April 30, 2020
Research and Development COVID-19, Gilead, coronavirus, remdesivir

The first findings of two new studies have been revealed detailing the efficacy of Gilead’s antiviral therapy remdesivir in the …

News
facemask

Men most likely to exhibit the worst COVID-19 symptoms, according to a new study

April 30, 2020
Business Services COVID-19, coronavirus

Research into coronavirus cases in Shenzhen, China found that men were 2.5 times as likely to exhibit severe symptoms. The …

News
korean_1

Arizona GOP lawmakers and AAPS say hydroxychloroquine has 90% chance of helping COVID-19 patients, but data is not based on clinical trials

April 29, 2020
Research and Development chloroquine, hydroxychloroquine

The Association of American Physicians and Surgeons (AAPS) wrote a letter to Republican Arizona Governor Doug Ducey urging the wider …

News
shutterstock

Phase 3 Libtayo monotherapy trial halted early due to strong benefit in advanced non-small cell lung cancer

April 29, 2020
Research and Development Cancer, Libtayo, Regeneron, Sanofi, lung cancer

A Phase 3 study of Sanofi and Regeneron’s Libtayo (cemiplimab) as a monotherapy for advanced or metastatic non-small cell lung …

News
aussss

Australia calls for investigation into China’s coronavirus response

April 29, 2020
Research and Development Australia, COVID-19, China, coronavirus

Scott Morrison, the Australian Prime Minister, has called for an investigation into the origins of the COVID-19 coronavirus, as Australia …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

April 29, 2020
Research and Development BARDA, COVID-19, coronavirus, hydroxychloroquine

Hydroxychloroquine continues to feature in coronavirus news. Rick Bright, the Director of BARDA, alleges he was pushed out of his …

News
novartis_outside_1

EU approval for Novartis’ Cosentyx in active non-radiographic axial spondyloarthritis

April 29, 2020
Research and Development, Sales and Marketing Cosentyx, EU, Novartis, axial spondyloarthritis, pharma

Novartis has revealed that the European Commission has moved to approve Cosentyx (secukinumab) for the treatment of active non-radiographic axial …

News

Nearly half of Americans believe COVID-19 was created in a lab, according to a new survey

April 28, 2020
Manufacturing and Production COVID-19, coronavirus, survey

Almost half of Americans believe that the coronavirus was created in a lab, according to an April survey of 6,300 …

News
pharmafocus_may_2020_cover

The May 2020 issue of Pharmafocus is available to read free online now!

April 28, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The latest monthly edition of Pharmafocus, the May 2020 issue, is available to read for free online now!

News
janssen_latest_logo_on_sign_closer

NICE backtracks to approve Janssen’s Stelara in ulcerative colitis

April 28, 2020
Manufacturing and Production, Research and Development Janssen, NICE, Stelara, ulcerative colitis

NICE has recommended Janssen’s Stelara (ustekinumab) for the treatment of moderately to severely active ulcerative colitis (UC), a move which …

News
korean

South Korean researchers start testing pancreatitis drug in COVID-19 patients

April 28, 2020
Manufacturing and Production COVID-19, Pancreas, Pancreatitis, coronavirus

The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 …

News
children_with_mask

12 British children hospitalised with rare condition linked to COVID-19

April 28, 2020
Manufacturing and Production COVID-19, NHS, NHS UK, coronavirus

12 children have fallen ill across the UK with a new and potentially fatal combination of symptoms linked to COVID-19. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025